LONDON–(BUSINESS WIRE)–#Biotechnology–Biotechnology and healthcare companies are focusing on the development of new technologies and products to analyze the molecular level of blood group typing. Companies are also developing products which enable efficient blood testing workload management thereby helping them to increase their market share. For instance, the PreciseType HEA Test developed by Immucor has received US FDA approval and is used for sickle cell trait (SCT) screening in blood donors. Thus, the increasing R&D activities and product innovations related to the analysis of the molecular level of blood group typing will drive the growth of the market. Furthermore, this industry research report also presents a competitive analysis of the market by product (consumables, instruments, and software) and geography (Asia, Europe, North America, and ROW).
Competitive vendor landscape
The global blood group typing market is highly competitive with major vendors such as Agena Bioscience, Bio-Rad Laboratories, Danaher, Merck KGaA, and Ortho Clinical Diagnostics, competing on the basis of price, quality, and product/service offerings.
“North America will account for the highest growth of the blood group typing market throughout the forecast period. The presence of several vendors offering blood group typing consumables, software, and instruments is identified as one of the major factors driving market growth in this region,” says a senior analyst at Technavio
Top five blood group typing market vendors
Agena Bioscience
Agena Bioscience operates through the segment: unified business segment. The company’s key offerings include Hemo ID DQS Panel and Hemo ID software.
Bio-Rad Laboratories
Bio-Rad Laboratories operates through three segments: life science, clinical diagnostics, and other operations. The company’s key offerings include: ABO/Rh Reagents and TANGO infinity System.
Danaher
Danaher operates through four segments: life sciences, diagnostics, dental, environmental & applied solutions. The company’s key offerings include PK7300 Automated Microplate System.
Merck KGaA
Merck KGaA operates through three segments: healthcare, life science, and performance materials. The company’s key offerings include BIOSCOT Blood Typing Reagents and Blood typing intermediates FFMU.
Ortho Clinical Diagnostics
Ortho Clinical Diagnostics operates through the segment: unified business segment. The company’s key offerings includes: ORTHO VISION Analyzer and ID-Micro Typing System.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
Browse Related Reports:
- Global Influenza Diagnostics Market 2019-2023 – The market research study identifies Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., and Thermo Fisher Scientific Inc., as the leading players in the global influenza diagnostics market.
- Global Fecal Occult Testing Market 2019-2023 – The market research study identifies Abbott Laboratories, bioMérieux SA, Danaher Corp., Eiken Chemical Co. Ltd., and Quidel Corp., as the leading players in the global fecal occult testing market.
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at media@technavio.com.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
technavio.com
media@technavio.com.